Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

Université Laval

$105,000.00

Enhancing adherence to adjuvant endocrine therapy (AET) among breast cancer survivors: Pilot study of the SOIE program

FY 2016-17

Summary
Adjuvant endocrine therapy (AET) is prescribed to women with hormone sensitive breast tumours, representing 75% of breast cancer cases. Five years was the standard length of prescription but this has been extended to 10 years for some women. AET significantly reduces the risks of recurrence and mortality. However, non-adherence to AET is common as it is estimated that 31-47% of women do not persist with treatment for the recommended minimum of 5 years. Taking AET less than 80% of the days prescribed has negative consequences on mortality (20% increased risk compared to taking more than 80%). The few existing AET adherence-enhancing interventions that have been evaluated have provided inconclusive results. In collaboration with healthcare professionals and breast cancer survivors, the team of Dr. Lauzier has developed the SOIE (Soutien, Outils, Information, Entraide) program for women who have a first AET prescription. This program includes group sessions (in person and online) and short individual interventions tailored to women's support and information needs. We will pilot test the SOIE program to evaluate: a) effect of the program on factors expected to influence AET adherence; b) program acceptability; c) feasibility of program delivery. This pilot randomized controlled trial (RCT) includes 50 women who will receive the program and 50 women who will receive the standard usual care. Quantitative and qualitative data will be collected among participating women and health professionals delivering the program. Results from this pilot study will be used to optimize this adherence-enhancing program and plan a multicenter RCT to evaluate cost-effectiveness. By optimizing the use of an existing treatment with demonstrated efficacy, the program the potential to improve the treatment experience for women prescribed an AET. It will also contribute to efforts to increase breast cancer survival and reduce the economic burden for the healthcare system.
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
365494
Name
Humphries Brittany R
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
Doctoral Research Awards - B
Projecttitle
Enhancing adherence to adjuvant endocrine therapy (AET) among breast cancer survivors: Pilot study of the SOIE program
Programtype2
Studentship Programs
Orgnameinp2
Université Laval
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Adjuvant Endocrine Therapy; Breast Cancer; Intervention; Medication Adherence; Mixed Methods; Pilot Study; Randomized Control Trial
Abstract
Adjuvant endocrine therapy (AET) is prescribed to women with hormone sensitive breast tumours, representing 75% of breast cancer cases. Five years was the standard length of prescription but this has been extended to 10 years for some women. AET significantly reduces the risks of recurrence and mortality. However, non-adherence to AET is common as it is estimated that 31-47% of women do not persist with treatment for the recommended minimum of 5 years. Taking AET less than 80% of the days prescribed has negative consequences on mortality (20% increased risk compared to taking more than 80%). The few existing AET adherence-enhancing interventions that have been evaluated have provided inconclusive results. In collaboration with healthcare professionals and breast cancer survivors, the team of Dr. Lauzier has developed the SOIE (Soutien, Outils, Information, Entraide) program for women who have a first AET prescription. This program includes group sessions (in person and online) and short individual interventions tailored to women's support and information needs. We will pilot test the SOIE program to evaluate: a) effect of the program on factors expected to influence AET adherence; b) program acceptability; c) feasibility of program delivery. This pilot randomized controlled trial (RCT) includes 50 women who will receive the program and 50 women who will receive the standard usual care. Quantitative and qualitative data will be collected among participating women and health professionals delivering the program. Results from this pilot study will be used to optimize this adherence-enhancing program and plan a multicenter RCT to evaluate cost-effectiveness. By optimizing the use of an existing treatment with demonstrated efficacy, the program the potential to improve the treatment experience for women prescribed an AET. It will also contribute to efforts to increase breast cancer survival and reduce the economic burden for the healthcare system.
Competitiondate
201610
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Humphries, Brittany R
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~